Dr. Matthias LeuenbergerDelegate Novartis Switzerland
Switzerland has a strong commitment to intellectual property and a great research environment with excellent universities.
evolaris aviation gmbh – a spin-off of the Bern University of Applied science – has developed an electrical high power aerobatic motor for the swiss aerobatic aircraft VOTEC 221 in the past 2 years. TEST
Medical Application of Virtual and Augmented Reality Tools. With the Virtual Reality tool Specto, doctors can interact in a three-dimensional space with the patient data prior to surgery.
MIRACLE, short for Minimally Invasive Robot-Assisted Computer-guided LaserosteotomE, aims to develop a robotic endoscope to perform contact-free bone surgery with laser light.
IPS Biopharma is a biotech company developing a proprietary drug for use in the innovative cancer immunotherapy inCVAX for the treatment of solid metastatic tumors.
Modern pharmaceutical development is tailored to the chemical and physical characteristics of active organic compounds. Obtaining a polymorph portfolio of a compound is a demanding process. With its advantages, electron diffraction represents one of the most promising fields of research for unlocking new possibilities in structure-based drug discovery.
The results of the research and development activities in chemical, pharmaceutical and many other areas often depend on the correctly identified structure of the analyzed sample. X-Ray Powder Diffraction (XRPD) is considered the gold standard method for identifying and quantifying crystalline solid forms and provides the industry with crucial data.
Membrane protein drug targets represent a significant challenge for high-resolution three-dimensional structure determination limiting the discovery and development of novel medicines. leadXpro AG, a company at PARK INNOVAARE, successfully tackles the membrane protein structure identification challenge to advance the drug discovery process and bring better drugs to the market.
Storing solar energy as hydrogen is a promising way for developing comprehensive renewable energy systems. Building on a unique idea, EPFL scientists have now developed a simple, unconventional method to fabricate high-quality, efficient solar panels for direct solar hydrogen production with low cost.
The exact knowledge and understanding of a molecule’s structure underpin all the substantial progress in chemical and pharmaceutical research. Using state-of-the-art technologies at the Paul Scherrer Institute (PSI), the company Crystallise! has achieved unprecedented results in absolute configuration determination of a small single crystal of a light atom compound.
Inhale, then exhale. This simple act could now save lives. A technology developed in part at EPFL can quickly identify the presence of a head and neck cancer, such as of the throat or mouth by analysing people's breath. The new device, equipped with extremely sensitive sensors, has been tested on patients and operates with a computer or even a mobile phone.
EPFL scientists have developed a method that improves the accuracy of DNA sequencing up to a thousand times. The method, which uses nanopores to read individual nucleotides, paves the way for better – and cheaper – DNA sequencing. Reading the exact make-up of genes, scientists can detect mutations, or even identify different organisms.
Drug discovery and design, precision/personalized medicine, medtech, biotech, diagnostics, biomedical engineering, nutrition, human physiologyMore
Data security (for example blockchain), data analytics, artificial intelligence, storage technologies, the Internet of Things (IoT), smart sensors, cloud computing, bioinformaticsMore
Energy storage, smart grids, power generation, smart building / living, energy/resource efficiency, green chemistry, alternative energy sourcesMore
Aviation and space, autonomous driving, avionics and drones, electric mobility and batteries, traffic planning and transport systems, mobility infrastructureMore
Robotics, automation, industry 4.0, advanced manufacturing, accelerator technology, nondestructive testing, new materials, nanotechnology, microelectronicsMore
Collaborate with world-class academic partners. Easy access to the best talents and researchers
Find exciting high-tech start-ups and spin-offs
Exchange ideas and forge partnerships with R&D teams from top international companies
Industrial liaison officers to help your R&D staff to maximize their opportunities
Approximately 200,000 square meters of high-end laboratories, offices, conference rooms and coworking spaces. Large, accelerator-based research facilities.
Business-friendly and politically stable environment
More than 40 hectares of development area
Access to Swiss and EU research funding
Very high quality of life, attractive for top talents and their families